This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, M. Y. Articles by Prendergast, G. C. Search for Related Content PubMed PubMed Citation Articles by Chang, M. Y. Articles by Prendergast, G. C.

Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer

¹ Lankenau Institute for Medical Research, and ² Lung Cancer Program, Lankenau Hospital, Wynnewood, Pennsylvania; ³ Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer Center, Houston, Texas; ⁴ Department of Pathology, Duke University Medical Center, Durham, North Carolina; and ⁵ Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

Requests for reprints: George C. Prendergast, Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096. Phone: 610-645-8475; Fax: 610-645-8533; E-mail: prendergast{at}limr.org.

Age is the major risk factor for cancer, but few genetic pathways that modify cancer incidence during aging have been described. Bin1 is a prototypic member of the BAR adapter gene family that functions in vesicle dynamics and nuclear processes. Bin1 limits oncogenesis and is often attenuated in human cancers, but its role in cancer suppression has yet to be evaluated fully in vivo. In the mouse, homozygous deletion of Bin1 causes developmental lethality, so to assess this role, we examined cancer incidence in mosaic null mice generated by a modified Cre-lox technology. During study of these animals, one notable phenotype was an extended period of female fecundity during aging, with mosaic null animals retaining reproductive capability until the age of 17.3 ± 1.1 months. Through 1 year of age, cancer incidence was unaffected by Bin1 ablation; however, by 18 to 20 months of age, 50% of mosaic mice presented with lung adenocarcinoma and 10% with hepatocarcinoma. Aging mosaic mice also displayed a higher incidence of inflammation and/or premalignant lesions, especially in the heart and prostate. In mice where colon tumors were initiated by a ras-activating carcinogen, Bin1 ablation facilitated progression to more aggressive invasive status. In cases of human lung and colon cancers, immunohistochemical analyses evidenced frequent attenuation of Bin1 expression, paralleling observations in other solid tumors. Taken together, our findings highlight an important role for Bin1 as a negative modifier of inflammation and cancer susceptibility during aging. [Cancer Res 2007;67(16):7605–12]

This article has been cited by other articles:

				P. Fernando, J. S. Sandoz, W. Ding, Y. de Repentigny, S. Brunette, J. F. Kelly, R. Kothary, and L. A. Megeney Bin1 Src Homology 3 Domain Acts as a Scaffold for Myofiber Sarcomere Assembly J. Biol. Chem., October 2, 2009; 284(40): 27674 - 27686. [Abstract] [Full Text] [PDF]

				E. Kennah, A. Ringrose, L. L. Zhou, S. Esmailzadeh, H. Qian, M.-w. Su, Y. Zhou, and X. Jiang Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells Blood, May 7, 2009; 113(19): 4646 - 4655. [Abstract] [Full Text] [PDF]

				A. Ramalingam, J. B. Duhadaway, E. Sutanto-Ward, Y. Wang, J. Dinchuk, M. Huang, P. S. Donover, J. Boulden, L. M. McNally, A. P. Soler, et al. Bin3 Deletion Causes Cataracts and Increased Susceptibility to Lymphoma during Aging Cancer Res., March 15, 2008; 68(6): 1683 - 1690. [Abstract] [Full Text] [PDF]